#oncology
Lupin eyes $500 mn biosimilars revenue in medium term, to ramp capacity
The company plans to soon start the funding process for its oncology spin-off, Kaveri Therapeutics, which houses two specialised oncology programmes
KIMS Hospitals Launches KIMS Renova Oncology Institute in Bengaluru to Advance Cancer Care
Stay updated with Business News This Week – your source for the latest business news weekly, market updates, and top business stories
PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis
Acquired drug resistance is a major cause of failure in gastric cancer treatment. The protein tyrosine phosphatase receptor type E (PTPRE) plays an oncogenic role in certain tumours; however, its function in chemotherapy-resistant gastric cancer remains uncle…
We are the largest oncology player in India, says Zydus MD; eyes US speciality push
Zydus’ oncology business is supported by early entry into complex biologics and targeted therapies, along with structured patient support programmes that have improved access across treatment lines
Why Indian doctors are recommending genome tests before prescriptions
A select number of physicians are using pharmacogenomic and whole-genome data to refine treatment plans, particularly for cardiology and oncology. The catch: The test isn't on any standard panel, but this may be the beginning of an effective way of practicing…
India Cell Based Assay Market Forecasts 2026-2035: Strategic Government Initiatives Bolster India's Biopharma Innovation
The India cell-based assay market is poised for growth due to increased drug discovery activities, automation in high-throughput screening, and outsourcing to CROs. Opportunities exist in 3D cell culture models, AI integration, stem cell research, oncology, a…
Oncology Companion Diagnostics Market 2026-2035: Opportunity Analysis for the $5.7 Billion Industry
Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Oncology Companion Diagnostic Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.
Sun's strong gravity helps India Inc's pull
Sun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies Sun Pharma's portfolio in critical areas like dermatology, oncology, and women’s health, while providing a gateway to new…